BioSpace News Archive

Business

Sanofi Delivers 2017 Business EPS(1) in Line With Guidance

Fourth-quarter and 2017 accounts reflect the acquisition of the former Boehringer Ingelheim Consumer Healthcare (CHC) business.

February 7, 2018

·

75 min read

Pharm Country

World’s First Single-Port Prostatectomy Using Titan Medical’s SPORT Surgical System Completed in a Preclinical Setting

The procedure is part of the feasibility and validation studies intended to support submissions to regulators in both the United States and European Union.

February 7, 2018

·

5 min read

Policy

Therapix Biosciences Completes Pre-IND Communication With FDA on THX-110 for Tourette Syndrome: Clinical Development to Proceed as Projected

Therapix announced today that it has held a pre-Investigational New Drug communication with the FDA to discuss the regulatory pathway for the development of THX-110 for the treatment of Tourette Syndrome.

February 7, 2018

·

6 min read

Abbott’s App for FreeStyle Libre System Now Available in Europe for Both iPhone and Android

Abbott announced today the FreeStyle LibreLink app is now available in Europe for use with compatible smartphones2.

February 7, 2018

·

5 min read

Policy

Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification

The Company received the renewed GMP certificate evidencing compliance on January 31, 2018.

February 7, 2018

·

3 min read

Policy

Galmed Granted ‘Preferred Technological Enterprise’ Status

The grant of the status means that Galmed R&D will be subject to a reduced Israeli corporate tax rate that will range between 6%-12% on any future taxable “technological income” which includes sales, licenses and royalties from its IP protected products.

February 7, 2018

·

6 min read

Drug Development

Abeona Therapeutics Reports on Initial Safety and Biopotency Signals in MPS IIIB Gene Therapy Clinical Trial

Abeona plans to enroll a total of three patients in Cohort 1 (2E13 vg/kg) before dose-escalating to the Cohort 2 dose (5E13 vg/kg).

February 7, 2018

·

8 min read

BioMidwest

Medical College of Wisconsin Release: CAR-T Cell Immunotherapy Clinical Trial Cancer Patient in Remission; First-in-the-World Cancer Treatment Shows Promise

Bret C., 52, of Appleton, Wis., is the first patient to participate in this novel clinical trial.

February 7, 2018

·

2 min read

Drug Development

Impel NeuroPharma Announces Positive Results of Phase I Clinical Trial of INP104 for Treatment of Acute Migraine Headache

INP104 is a novel dihydroergotamine product dosed via Impel’s proprietary Precision Olfactory Delivery, or POD, intranasal delivery device.

February 7, 2018

·

3 min read

Business

Dyadic International Announces Research and Development Collaboration to Produce An Active Ingredient in C1

The deal will explore the potential of its C1 technology to produce an important active moiety with an integrated, global biotech company.

February 7, 2018

·

4 min read